322 related articles for article (PubMed ID: 28196901)
1. Novel Variant in the
Swayne LA; Murphy NP; Asuri S; Chen L; Xu X; McIntosh S; Wang C; Lancione PJ; Roberts JD; Kerr C; Sanatani S; Sherwin E; Kline CF; Zhang M; Mohler PJ; Arbour LT
Circ Cardiovasc Genet; 2017 Jan; 10(1):. PubMed ID: 28196901
[TBL] [Abstract][Full Text] [Related]
2. Defining the cellular phenotype of "ankyrin-B syndrome" variants: human ANK2 variants associated with clinical phenotypes display a spectrum of activities in cardiomyocytes.
Mohler PJ; Le Scouarnec S; Denjoy I; Lowe JS; Guicheney P; Caron L; Driskell IM; Schott JJ; Norris K; Leenhardt A; Kim RB; Escande D; Roden DM
Circulation; 2007 Jan; 115(4):432-41. PubMed ID: 17242276
[TBL] [Abstract][Full Text] [Related]
3. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function.
Mohler PJ; Splawski I; Napolitano C; Bottelli G; Sharpe L; Timothy K; Priori SG; Keating MT; Bennett V
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9137-42. PubMed ID: 15178757
[TBL] [Abstract][Full Text] [Related]
4. Common human ANK2 variant confers in vivo arrhythmia phenotypes.
Musa H; Murphy NP; Curran J; Higgins JD; Webb TR; Makara MA; Wright P; Lancione PJ; Lubbers ER; Healy JA; Smith SA; Bennett V; Hund TJ; Kline CF; Mohler PJ
Heart Rhythm; 2016 Sep; 13(9):1932-40. PubMed ID: 27298202
[TBL] [Abstract][Full Text] [Related]
5. Targeted mutational analysis of ankyrin-B in 541 consecutive, unrelated patients referred for long QT syndrome genetic testing and 200 healthy subjects.
Sherman J; Tester DJ; Ackerman MJ
Heart Rhythm; 2005 Nov; 2(11):1218-23. PubMed ID: 16253912
[TBL] [Abstract][Full Text] [Related]
6. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death.
Mohler PJ; Schott JJ; Gramolini AO; Dilly KW; Guatimosim S; duBell WH; Song LS; Haurogné K; Kyndt F; Ali ME; Rogers TB; Lederer WJ; Escande D; Le Marec H; Bennett V
Nature; 2003 Feb; 421(6923):634-9. PubMed ID: 12571597
[TBL] [Abstract][Full Text] [Related]
7. Ankyrin-B Q1283H Variant Linked to Arrhythmias Via Loss of Local Protein Phosphatase 2A Activity Causes Ryanodine Receptor Hyperphosphorylation.
Zhu W; Wang C; Hu J; Wan R; Yu J; Xie J; Ma J; Guo L; Ge J; Qiu Y; Chen L; Liu H; Yan X; Liu X; Ye J; He W; Shen Y; Wang C; Mohler PJ; Hong K
Circulation; 2018 Dec; 138(23):2682-2697. PubMed ID: 30571258
[TBL] [Abstract][Full Text] [Related]
8. A KCNQ1 V205M missense mutation causes a high rate of long QT syndrome in a First Nations community of northern British Columbia: a community-based approach to understanding the impact.
Arbour L; Rezazadeh S; Eldstrom J; Weget-Simms G; Rupps R; Dyer Z; Tibbits G; Accili E; Casey B; Kmetic A; Sanatani S; Fedida D
Genet Med; 2008 Jul; 10(7):545-50. PubMed ID: 18580685
[TBL] [Abstract][Full Text] [Related]
9. Targeting and stability of Na/Ca exchanger 1 in cardiomyocytes requires direct interaction with the membrane adaptor ankyrin-B.
Cunha SR; Bhasin N; Mohler PJ
J Biol Chem; 2007 Feb; 282(7):4875-4883. PubMed ID: 17178715
[TBL] [Abstract][Full Text] [Related]
10. Common genetic variants in ANK2 modulate QT interval: results from the KORA study.
Sedlacek K; Stark K; Cunha SR; Pfeufer A; Weber S; Berger I; Perz S; Kääb S; Wichmann HE; Mohler PJ; Hengstenberg C; Jeron A
Circ Cardiovasc Genet; 2008 Dec; 1(2):93-9. PubMed ID: 20031550
[TBL] [Abstract][Full Text] [Related]
11. The variant hERG/R148W associated with LQTS is a mutation that reduces current density on co-expression with the WT.
Mechakra A; Vincent Y; Chevalier P; Millat G; Ficker E; Jastrzebski M; Poulin H; Pouliot V; Chahine M; Christé G
Gene; 2014 Feb; 536(2):348-56. PubMed ID: 24334129
[TBL] [Abstract][Full Text] [Related]
12. Ankyrin-B p.S646F undergoes increased proteasome degradation and reduces cell viability in the H9c2 rat ventricular cardiomyoblast cell line.
Chen L; Choi CSW; Sanchez-Arias JC; Arbour LT; Swayne LA
Biochem Cell Biol; 2020 Apr; 98(2):299-306. PubMed ID: 31965814
[TBL] [Abstract][Full Text] [Related]
13. A Novel Mechanism for Human Cardiac Ankyrin-B Syndrome due to Reciprocal Chromosomal Translocation.
Huq AJ; Pertile MD; Davis AM; Landon H; James PA; Kline CF; Vohra J; Mohler PJ; Delatycki MB
Heart Lung Circ; 2017 Jun; 26(6):612-618. PubMed ID: 27916589
[TBL] [Abstract][Full Text] [Related]
14. ANK2 functionally interacts with KCNH2 aggravating long QT syndrome in a double mutation carrier.
Gessner G; Runge S; Koenen M; Heinemann SH; Koenen M; Haas J; Meder B; Thomas D; Katus HA; Schweizer PA
Biochem Biophys Res Commun; 2019 May; 512(4):845-851. PubMed ID: 30929919
[TBL] [Abstract][Full Text] [Related]
15. Defining new insight into atypical arrhythmia: a computational model of ankyrin-B syndrome.
Wolf RM; Mitchell CC; Christensen MD; Mohler PJ; Hund TJ
Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1505-14. PubMed ID: 20729400
[TBL] [Abstract][Full Text] [Related]
16. Ankyrin-based cardiac arrhythmias: a new class of channelopathies due to loss of cellular targeting.
Mohler PJ; Bennett V
Curr Opin Cardiol; 2005 May; 20(3):189-93. PubMed ID: 15861006
[TBL] [Abstract][Full Text] [Related]
17. Cardiac ankyrins in health and disease.
Hashemi SM; Hund TJ; Mohler PJ
J Mol Cell Cardiol; 2009 Aug; 47(2):203-9. PubMed ID: 19394342
[TBL] [Abstract][Full Text] [Related]
18. Ankyrin-B syndrome: a case of sinus node dysfunction, atrial fibrillation and prolonged QT in a young adult.
Robaei D; Ford T; Ooi SY
Heart Lung Circ; 2015 Feb; 24(2):e31-4. PubMed ID: 25456501
[TBL] [Abstract][Full Text] [Related]
19. [Anchoring proteins and cardiac sudden death: how and why?].
Pourrier M; Nattel S
Med Sci (Paris); 2004 Apr; 20(4):437-41. PubMed ID: 15124116
[TBL] [Abstract][Full Text] [Related]
20. alpha-1-syntrophin mutation and the long-QT syndrome: a disease of sodium channel disruption.
Wu G; Ai T; Kim JJ; Mohapatra B; Xi Y; Li Z; Abbasi S; Purevjav E; Samani K; Ackerman MJ; Qi M; Moss AJ; Shimizu W; Towbin JA; Cheng J; Vatta M
Circ Arrhythm Electrophysiol; 2008 Aug; 1(3):193-201. PubMed ID: 19684871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]